A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19
- First Posted Date
- 2021-06-25
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- RSV Therapeutics LLC
- Target Recruit Count
- 274
- Registration Number
- NCT04940182
- Locations
- 🇷🇺
Limited Liability Company "Research Center Eco-Safety", Saint Petersburg, Russian Federation
🇷🇺Saint Petersburg State Budgetary Institution of Healthcare "City Polyclinic No. 4", Saint Petersburg, Russian Federation
🇷🇺State Budgetary Institution of Healthcare of Moscow "City Polyclinic No. 2 of the Moscow Department of Healthcare", Moscow, Russian Federation
A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19
- First Posted Date
- 2020-07-27
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- RSV Therapeutics LLC
- Target Recruit Count
- 118
- Registration Number
- NCT04487574
- Locations
- 🇷🇺
Saint Petersburg State Budgetary Institution of Healthcare "City Pokrovskaya Hospital", Saint Petersburg, Russian Federation
🇷🇺Municipal Budgetary Institution of Healthcare "Central City Hospital of Novoshakhtinsk", Novoshakhtinsk, Rostov Region, Russian Federation
🇷🇺Saint Petersburg State Budgetary Institution of Healthcare "City Hospital No. 40 of Kurortny District", Saint Petersburg, Russian Federation